YOLFTbeta
Nitrasanata Dharma Tbk

Nitrasanata Dharma Tbk

JECX · JK · Healthcare / Medical Care Facilities

935.00IDR+25.00 (+2.75%)

Price History

Full chart

Market Stats

Previous Close910.00
Open910.00
Day Range885.00 – 935.00
52-Week Range1,200.00 – 1,950.00
Volume238.50K
Market Cap4.25T
P/E (TTM)68.97
Forward P/E0.00
EPS18.92
Dividend Yield0.00%
50-Day Avg1,378.00
200-Day Avg1,391.29

About

PT Nitrasanata Dharma operates as a provider of eye health services in Indonesia. The company provides ophthalmic services including cataract, lens and refractive surgery, glaucoma treatment, retina care, okuloplasty and orbital reconstruction, pediatric ophthalmology and strabismus management, contact lens services, infection and immunology care, neuro-ophthalmology, dry eye treatment, and ophthalmic trauma services. In addition, it offers solutions, such as eye check diagnostics, tele-ophthalmology consultations, and services through the thyroid eye center. PT Nitrasanata Dharma was founded in 1984 and is headquartered in Jakarta Pusat, Indonesia.

Company Details

  • SectorHealthcare
  • IndustryMedical Care Facilities
  • CEODr. Johan A. M. M. Hutauruk
  • Employees1.16K
  • HeadquartersJl. Teuku Cik Ditiro No. 46, Jakarta Pusat, Indonesia, 10310, Indonesia
  • Websitehttps://www.jec.co.id

Leadership

  • Dr. Johan A. M. M. HutaurukPresident Director · b. 1968
  • Mr. Budi Djatmiko Musaffa B.B.A.Finance Director & Director · b. 1960
  • Dr. Emma RusmayaniHead of Cibubur
  • Dr. Devina Nur AnnisaHead of Tambora
  • Dr. Nashrul IhsanHead of Bekasi
  • Dr. Zeiras Eka DjamalHead of Cinere
  • Dr. Andhika Guna DharmaHead of Candi Eye Center, Semarang
  • Dr. Dian ArumdiniHead of JEC JAVA @ Surabaya
  • Dr. Kukuh PrasetyoHead of JEC Anwari @ Purwokerto
  • Dr. Ardy GisnawanHead of JEC Orbita @ Makassar

Financials

Income Statement

Currency: IDR2023-12-312024-12-312025-12-31
Total Revenue825.09B887.72B926.76B
Growth (%)-+7.59%+4.40%
Cost of Revenue309.58B333.18B350.07B
Gross Profit515.50B554.54B576.69B
Gross Margin62.48%62.47%62.23%
Operating Expense339.23B443.13B451.06B
Operating Income176.27B111.41B125.63B
Operating Margin21.36%12.55%13.56%
EBITDA220.50B179.04B196.64B
EBITDA Margin26.73%20.17%21.22%
Net Income127.28B62.47B72.50B
Net Income Margin15.43%7.04%7.82%
Interest Expense12.61B23.70B26.90B
Interest Expense % of Total Revenue1.53%2.67%2.90%

Balance Sheet

Currency: IDR2023-12-312024-12-312025-12-31
Total Assets1.35T1.42T1.45T
Total Liabilities522.49B611.14B640.33B
Total Equity675.61B659.35B666.64B
Cash314.97B270.31B244.13B
Net Debt-28.00B23.27B

Cash Flow

Currency: IDR2023-12-312024-12-312025-12-31
Capital Expenditure202.92B154.92B103.47B
Free Cash Flow20.02B-11.58B69.89B
Dividends Paid66.27B82.85B62.94B
Dividend Paid to FCF331.10%-715.55%90.06%

Key Statistics & Ratios

Market Cap4.25T
Enterprise Value4.75T
Trailing P/E68.97
Forward P/E0.00
Price / Sales4.51
Price / Book7.00
EPS18.92
Book Value194.88
Revenue (TTM)941.92B
Gross Profit (TTM)581.52B
EBITDA224.86B
Profit Margin6.61%
Operating Margin10.85%
Return on Equity8.94%
Return on Assets5.45%
Shares Outstanding3.25B
Shares Float64.30M
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%